Endo GI Medical
A privately-owned Israeli company, backed by NGT3VC. EndoGI develops Stenting Placement Delivery Systems for the treatment of biliary, pancreatic and uretral stenosis and strictures in one cannulation while keeping the guide wire in place.
EndoGI novel delivery systems enable insertion and placement of one plastic stent or more in the common bile and hepatic ducts and in the ureters with one passage of the delivery system while securing and maintaining access of the guide wire at the targeted anatomical site.
EndoGI has received two different FDA marketing clearances-510 (k) regulatory approvals on single and multiple stent and delivery system and has launched initial post regulatory approval clinical studies- First in Human.
